⌘K

Home/Filings/4/0001104659-23-105924

4//SEC Filing

Dudley Robert Michael 4

Accession 0001104659-23-105924

CIK 0001829635other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:37 PM ET

Size

4.8 KB

Accession

0001104659-23-105924

Insider Transaction Report

Form 4

Period: 2023-09-28

Transcode Therapeutics, Inc.RNAZ

Dudley Robert Michael

DirectorChief Executive Officer10% Owner

Transactions

Purchase
Common Stock
2023-09-28$0.51/sh+98,000$49,980→ 180,262 total

Footnotes (1)

[F1]Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.

Documents

1 file

4
tm2327413-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Transcode Therapeutics, Inc.

CIK 0001829635

Entity typeother

Related Parties

1

filerCIK 0001854161

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:37 PM ET
Size: 4.8 KB

View on SEC.gov